Shares of Sanjivani Paranteral were surging on Thursday as the company posted its latest shareholding data with the exchange.

What Happened: As per the latest data, ace investor Ashish Kacholia picked up a 3.17% stake in the company during the March quarter. His 3.7 lakh shares are worth around ₹6.7 crore.

The stock has been on an incredible run over the last year, going up over 300%. In the last 30 days, the stock has surged up over 25%.

See Also: Small Cap Stock Surges 5% As Mukul Agrawal Picks Up 1.16% Stake

Sanjivani Paranteral is a WHO-GMP-certified pharmaceutical company specializing in the manufacturing of injectables and oral solids. With over two-and-a-half decades of experience, the company primarily focuses on producing life-saving drugs.

They have a global presence with exports to over 25 countries. To meet the demands of a wide geographic area, Sanjivani Paranteral operates two WHO-GMP-certified manufacturing facilities located in Mumbai and Dehradun. The company came out with a public issue in January 1996.

Price Action: Shares of Sanjivani Paranteral were locked in 10% upper circuit at ₹168.60 on Thursday.

Read Next: Reliance-Backed Small Cap Stock Rockets 13% As Profit Surges 38% In Q4